{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:51:12Z","timestamp":1767894672825,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T00:00:00Z","timestamp":1545782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41440-018-0185-3","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T06:32:01Z","timestamp":1545805921000},"page":"329-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The ATRQ\u03b2-001 vaccine improves cardiac function and prevents postinfarction cardiac remodeling in mice"],"prefix":"10.1038","volume":"42","author":[{"given":"Yajie","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzhao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,26]]},"reference":[{"key":"185_CR1","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1161\/01.CIR.81.4.1161","volume":"81","author":"MA Pfeffer","year":"1990","unstructured":"Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990;81:1161\u201372.","journal-title":"Circulation"},{"key":"185_CR2","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1111\/jcmm.12551","volume":"19","author":"X Sui","year":"2015","unstructured":"Sui X, Wei H, Wang D. Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-\u03b21 and HIF-1\u03b1 in Ang II-mediated fibrosis after myocardial infarction. J Cell Mol Med. 2015;19:1773\u201382.","journal-title":"J Cell Mol Med"},{"key":"185_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myo-cardial infarction: from inflammation to Fibrosis. Circ Res. 2016;119:91\u2013112.","journal-title":"Circ Res"},{"key":"185_CR4","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1161\/CIRCULATIONAHA.107.704197","volume":"116","author":"M Bujak","year":"2007","unstructured":"Bujak M, Ren G, Kweon HJ, Dobaczewski M, Reddy A, Taffet G, et al. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation. 2007;116:2127\u201338.","journal-title":"Circulation"},{"key":"185_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.pcad.2015.11.004","volume":"58","author":"MH Strauss","year":"2016","unstructured":"Strauss MH, Hall AS. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction. Prog Cardiovasc Dis. 2016;58:473\u201382.","journal-title":"Prog Cardiovasc Dis"},{"key":"185_CR6","first-page":"178","volume":"107","author":"SG Vijan","year":"2009","unstructured":"Vijan SG. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients. J Indian Med Assoc. 2009;107:178\u201382.","journal-title":"J Indian Med Assoc"},{"key":"185_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1161\/HYPERTENSIONAHA.112.201020","volume":"61","author":"X Chen","year":"2013","unstructured":"Chen X, Qiu Z, Yang S, Ding D, Chen F, Zhou Y, et al. Effectiveness and safety of a terapeutic vaccine against angiotensin II receptor type 1 in hypertensive animals. Hypertension. 2013;61:408\u201316.","journal-title":"Hypertension"},{"key":"185_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/HJH.0000000000000835","volume":"34","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Wang S, Qiu Z, Song X, Pan Y, Hu X, et al. ATRQ\u03b2-001 vaccine prevents atherosclerosis in apolipoprotein E-null mice. J Hypertens. 2016;34:474\u201385.","journal-title":"J Hypertens"},{"key":"185_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00109-015-1343-6","volume":"94","author":"D Ding","year":"2016","unstructured":"Ding D, Du Y, Qiu Z, Yan S, Chen F, Wang M, et al. Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy. J Mol Med (Berl). 2016;94:207\u201318.","journal-title":"J Mol Med (Berl)"},{"key":"185_CR10","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/01.RES.0000130526.20854.fa","volume":"94","author":"M Nian","year":"2004","unstructured":"Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94:1543\u201353.","journal-title":"Circ Res"},{"key":"185_CR11","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.2174\/092986706777585086","volume":"13","author":"NG Frangogiannis","year":"2006","unstructured":"Frangogiannis NG. Targeting the inflammatory response in healing myocardial infarcts. Curr Med Chem. 2006;13:1877\u201393.","journal-title":"Curr Med Chem"},{"key":"185_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jjcc.2012.05.014","volume":"60","author":"Y Hojo","year":"2012","unstructured":"Hojo Y, Saito T, Kondo H. Role of apoptosis in left ventricular remodeling after acute myocardial infarction. J Cardiol. 2012;60:91\u20132.","journal-title":"J Cardiol"},{"key":"185_CR13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/CIRCRESAHA.117.311045","volume":"121","author":"SA Su","year":"2017","unstructured":"Su SA, Yang D, Wu Y, Xie Y, Zhu W, Cai Z, et al. EphrinB2 regulates cardiac fibrosis through modulating the interaction of Stat3 and TGF-\u03b2\/Smad3 signaling. Circ Res. 2017;121:617\u201327.","journal-title":"Circ Res"},{"key":"185_CR14","doi-asserted-by":"crossref","first-page":"e004406","DOI":"10.1161\/JAHA.116.004406","volume":"5","author":"R Zhu","year":"2016","unstructured":"Zhu R, Sun H, Yu K, Zhong Y, Shi H, Wei Y, et al. Interleukin-37 and dendritic cells treated with interleukin-37 plus troponin I ameliorate cardiac remodeling after myocardial infarction. J Am Heart Assoc. 2016;5:e004406.","journal-title":"J Am Heart Assoc"},{"key":"185_CR15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jacc.2011.10.863","volume":"59","author":"YH Liao","year":"2012","unstructured":"Liao YH, Xia N, Zhou SF, Tang TT, Yan XX, Lv BJ, et al. Interleukin-17A contributes to myocardial ischemia\/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. J Am Coll Cardiol. 2012;59:420\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"185_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00395-011-0232-6","volume":"107","author":"TT Tang","year":"2012","unstructured":"Tang TT, Yuan J, Zhu ZF, Zhang WC, Xiao H, Xia N, et al. Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res Cardiol. 2012;107:232.","journal-title":"Basic Res Cardiol"},{"key":"185_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00395-017-0622-5","volume":"112","author":"M Jung","year":"2017","unstructured":"Jung M, Ma Y, Iyer RP, DeLeon-Pennell KY, Yabluchanskiy A, Garrett MR, et al. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol. 2017;112:33.","journal-title":"Basic Res Cardiol"},{"key":"185_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1161\/CIRCRESAHA.108.178475","volume":"103","author":"JS Burchfield","year":"2008","unstructured":"Burchfield JS, Iwasaki M, Koyanagi M, Urbich C, Rosenthal N, Zeiher AM, et al. Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ Res. 2008;103:203\u2013211.","journal-title":"Circ Res"},{"key":"185_CR19","doi-asserted-by":"crossref","unstructured":"Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res. 2009;104:e9\u201318.","DOI":"10.1161\/CIRCRESAHA.108.188243"},{"key":"185_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","volume":"74","author":"M Bujak","year":"2007","unstructured":"Bujak M, Frangogiannis NG. The role of TGF-\u03b2 signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res. 2007;74:184\u201395.","journal-title":"Cardiovasc Res"},{"key":"185_CR21","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","volume":"51","author":"M Dobaczewski","year":"2011","unstructured":"Dobaczewski M, Chen W, Frangogiannis NG. Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling. J Mol Cell Cardiol. 2011;51:600\u20136.","journal-title":"J Mol Cell Cardiol"},{"key":"185_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1172\/JCI200519229","volume":"115","author":"LE Smythies","year":"2005","unstructured":"Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest. 2005;115:66\u201375.","journal-title":"J Clin Invest"},{"key":"185_CR23","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.cardiores.2004.07.017","volume":"64","author":"M Ikeuchi","year":"2004","unstructured":"Ikeuchi M, Tsutsui H, Shiomi T, Matsusaka H, Matsushima S, Wen J, et al. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc Res. 2004;64:526\u201335.","journal-title":"Cardiovasc Res"},{"key":"185_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1126\/science.2164258","volume":"249","author":"AM Lefer","year":"1990","unstructured":"Lefer AM, Tsao P, Aoki N, Palladino MA Jr.. Mediation of cardioprotection by transforming growth factor-beta. Science. 1990;249:61\u20134.","journal-title":"Science"},{"key":"185_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.yjmcc.2013.11.015","volume":"70","author":"AV Shinde","year":"2014","unstructured":"Shinde AV, Frangogiannis NG. Fibroblasts in myocardial infarction: a role in inflammation and repair. J Mol Cell Cardiol. 2014;70:74\u201382.","journal-title":"J Mol Cell Cardiol"},{"key":"185_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1006\/jmcc.1998.0902","volume":"31","author":"J Hao","year":"1999","unstructured":"Hao J, Ju H, Zhao S, Junaid A, Scammell-La Fleur T, Dixon IM. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol. 1999;31:667\u201378.","journal-title":"J Mol Cell Cardiol"},{"key":"185_CR27","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1161\/01.CIR.0000015602.94990.3D","volume":"105","author":"JL Mehta","year":"2002","unstructured":"Mehta JL, Chen HJ, Li DY. Protection of myocytes from hypoxia-reoxygenation injury by nitric oxide is mediated by modulation of transforming growth factor-beta1. Circulation. 2002;105:2206\u201311.","journal-title":"Circulation"},{"key":"185_CR28","doi-asserted-by":"publisher","first-page":"16341","DOI":"10.1074\/jbc.M109.094870","volume":"285","author":"H Unal","year":"2010","unstructured":"Unal H, Jagannathan R, Bhat MB, Karnik SS. Ligand-specific conformation of extracellular Loop-2 in the angiotensin II type 1 receptor. J Biol Chem. 2010;285:16341\u201350.","journal-title":"J Biol Chem"},{"key":"185_CR29","doi-asserted-by":"publisher","first-page":"18872","DOI":"10.1074\/jbc.M113.472381","volume":"288","author":"PC Wilson","year":"2013","unstructured":"Wilson PC, Lee MH, Appleton KM, El-Shewy HM, Morinelli TA, Peterson YK, et al. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers. J Biol Chem. 2013;288:18872\u201384.","journal-title":"J Biol Chem"},{"key":"185_CR30","doi-asserted-by":"publisher","first-page":"26155","DOI":"10.1074\/jbc.M114.595728","volume":"289","author":"RT Kendall","year":"2014","unstructured":"Kendall RT, Lee MH, Pleasant DL, Robinson K, Kuppuswamy D, McDermott PJ, et al. Arrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis. J Biol Chem. 2014;289:26155\u201366.","journal-title":"J Biol Chem"},{"key":"185_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep43920","volume":"7","author":"R Watanabe","year":"2017","unstructured":"Watanabe R, Suzuki JI, Wakayama K, Maejima Y, Shimamura M, Koriyama H, et al. A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction. Sci Rep. 2017;7:43920.","journal-title":"Sci Rep"},{"key":"185_CR32","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0140-6736(08)60381-5","volume":"371","author":"AC Tissot","year":"2008","unstructured":"Tissot AC, Maurer P, Nussberger J, Sabat R, Pfister T, Ignatenko S, et al. Effect of immunization against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a doubleblind, randomised, placebo-controlled phase IIa study. Lancet. 2008;371:821\u20137.","journal-title":"Lancet"},{"key":"185_CR33","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/hr.2011.137","volume":"34","author":"R Fogari","year":"2011","unstructured":"Fogari R, Zoppi A, Mugellini A, Maffioli P, Lazzari P, Derosa G. Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome. Hypertens Res. 2011;34:1321\u20136.","journal-title":"Hypertens Res"},{"key":"185_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12996-y","volume":"7","author":"X Hu","year":"2017","unstructured":"Hu X, Deng Y, Chen X, Zhou Y, Zhang H, Wu H, et al. Immune response of a novel ATR-AP205-001 conjugate anti-hypertensive vaccine. Sci Rep. 2017;7:12580.","journal-title":"Sci Rep"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0185-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0185-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0185-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:20:09Z","timestamp":1684617609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-018-0185-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,26]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1038\/s41440-018-0185-3","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,26]]},"assertion":[{"value":"28 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}